Notably, tumor-reactive CD8+ T cells - inclusive of cytotoxic, terminally exhausted, and pre-exhausted cells - present a higher proportion of CD27+ cells in comparison to all CD4+ T cells, Th17 cells, and naïve T cells (Figure 1D). The gene discussed is CD8A; the disease is neoplasm.